Financials
- Market Capitalization 12.64 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
33.02
売上高対価格比率
3.64
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 757 | EXEL Exelixis, Inc. - Common Stock | 55.26 USD | -1.50% | +2.83% | -2.11% | +41.55% | 13.69 B USD | ||
| 802 | CORT Corcept Therapeutics Incorporated - Common Stock | 116.93 USD | -2.40% | -3.75% | +23.08% | +59.37% | 12.64 B USD | ||
| 806 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 543.69 USD | +0.89% | +3.94% | +0.39% | +28.35% | 12.56 B USD | ||
| 809 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 88.59 USD | -0.59% | +0.50% | +3.54% | +126.57% | 12.51 B USD |